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Abstract: Francisella tularensis can cause the zoonotic disease tularemia and is partitioned into 
subspecies due to differences in chromosomal organization and virulence. The subspecies holarctica 
(type B) is generally considered more clonal than the other subpopulations with moderate virulence 
compared to the hypervirulent A.I clade. We performed whole genome sequencing (WGS) on six type 
B strains isolated from the blood of patients with tularemia within a one-year period from the same 
United States region, to better understand the associated pathogenicity. The WGS data were compared 
to the prototype strain for this subspecies, specifically FSC200, which was isolated from a patient with 
tularemia in Europe. These findings revealed 520–528 single nucleotide polymorphisms (SNPs) between 
the six United States type B strains compared to FSC200, with slightly higher A+T content in the latter 
strain. In contrast, comparisons between the six type B isolates showed that five of the six type B isolates 
had only 4–22 SNPs, while one of the strains had 47–53 SNPs. Analysis of SNPs in the core genome for 
the six United States type B isolates and the FSC200 strain gave similar results, suggesting that some of 
these mutations may have been nonsynonymous, resulting in altered protein function and 
pathogenicity. 
Keywords: Francisella tularensis subsp. holarctica (type B); human tularemia cases; human blood-derived 
F. tularensis; single nucleotide polymorphisms 
 
1. Introduction 
The zoonotic disease tularemia is caused by the facultative intracellular pathogen Francisella 
tularensis. The high infectivity, the ability to cause a lethal disease, and the previous use as a bioweapon 
has resulted in the classification of this pathogen as a Tier 1 select agent by the Centers for Disease Control 
and Prevention (CDC) [1,2]. This Gram-negative coccobacillus can infect numerous invertebrate and 
vertebrate species, including humans [3]. Transmission of tularemia can occur from oral, cutaneous, and 
conjunctival routes of exposure to F. tularensis, as well as inhalation. The latter case causes pneumonia 
tularemia and is the most lethal form, with as few as 10 organisms causing mortality if untreated [4]. In 
the environment, common vectors for this pathogen include arthropods (i.e., ticks, deer flies, and 
mosquitoes), rodents, and lagomorphs, along with predatory animals such as cats [3,5]. F. tularensis has 
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also been shown to survive in water and mud for several months [3]. However, the persistence and 
adaption of F. tularensis to various ecological niches in nature and numerous hosts is poorly understood. 
The clinically relevant F. tularensis subspecies include subsp. tularensis (also referred to as type A) 
and subsp. holarctica (also referred to as type B). The subsp. tularensis (type A) has been further 
subdivided into subtypes A.I and A.II due to differences in genomic organization and virulence. A.I 
strains are some of the most pathogenic bacteria known, while F. tularensis A.II and B strains generally 
cause a milder case of tularemia in humans [6]. Furthermore, these F. tularensis subpopulations have 
geographic associations. Type A strains are primarily restricted to North America, with the A.II clade 
being located predominately in the western region of the United States. In comparison, type B isolates 
are prevalent throughout the Northern Hemisphere and are endemic in Europe [7]. 
We report herein the isolation and characterization of six F. tularensis type B strains from clinical 
cases of tularemia within a one-year period between 2014 and 2015. Importantly, all six of these type B 
isolates were cultured from the blood of different patients with tularemia and all six of these individuals 
resided in the same region within the United States, specifically Scottsbluff, Nebraska in the Midwest. To 
determine if these six F. tularensis type B isolates were clonal and possibly acquired additional virulence 
factors, whole genome sequencing (WGS) was performed and their content was compared to each other 
and to the most studied type B strain FSC200. Despite the same foci for these human tularemia cases, our 
findings revealed an unexpected number of single nucleotide polymorphisms (SNPs), indicating that the 
etiologic agent in these six blood infections was due to different type B strains. Despite the supposition 
that F. tularensis type B strains cause a milder form of tularemia, these finding indicate that this clade is 
capable of causing a serious infection that could result in sepsis and possibly death if untreated. 
2. Materials and Methods 
2.1. Bacterial Strains and DNA Isolation 
The six F. tularensis subsp. holarctica (type B) strains were transferred to the University of Nebraska 
Medical Center (UNMC)/Nebraska Public Health Laboratory (NPHL) in Omaha following the 
requirements of the Federal Select Agent Program, as outlined in the Animal and Plant Health Inspection 
Service/CDC Form 2, Guidance Document for Request to Transfer Select Agents and Toxins [2]. 
Manipulation of viable culture material was performed by authorized individuals within a biosafety level 
3 laboratory certified for select agent work by the United States Department of Health and Human 
Services, using laboratory biosafety criteria according to the requirements of the Federal Select Agent 
Program. The identity of these six wild-type isolates as F. tularensis was confirmed by qualified personnel 
at NPHL, a reference laboratory in the National Public Health Laboratory Network, using CDC-
approved protocols. 
All Francisella isolates were grown on chocolate agar plates (Remel, Lenexa, Kansas, KS, USA) and 
incubated at 37 °C with 5% CO2 for three days before processing for DNA extraction. Genomic DNA 
from the six F. tularensis strains was isolated using cetyltrimethyl ammonium bromide (CTAB), according 
to standard procedures [8]. High molecular weight genomic DNA was confirmed by fractionation in an 
agarose gel and visualization by subsequent ethidium bromide staining. DNA concentration was 
determined by measuring the absorbance at 260 nm using a Qubit 3.0 fluorometer (Invitrogen, Carlsbad, 
CA, USA). The purity of the genomic DNA was evaluated by obtaining the ratio of the absorbance at 260 
nm and 280 nm (A260/280) utilizing a NanoDrop 1000 UV–visible spectrophotometer (Thermo Fisher, 
Waltham, MA, USA). 
2.2. Whole Genome Sequencing (WGS) 
F. tularensis genomic DNA libraries for the six different isolates were constructed using the Nextera 
XT Library Prep Kit (Illumina, San Diego, CA, USA), according to the manufacturer’s recommendations. 
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WGS using 250 bp paired-end chemistry was performed on the Illumina MiSeq platform (Illumina) at 
NPHL, according to the manufacturer’s instructions. A rate of clusters passing the filter of > 80%, a Phred 
quality score (QS30) of > 75%, and a cluster density of 600 to 1300 were used as parameters to assess the 
quality of the run. FastQC 0.11 was used to evaluate the quality of the sequencing reads, and the reads 
were trimmed with Trimmomatic 0.33 [9]. FastQC 0.11 was then utilized to recheck read quality. Next, 
de novo assembly was performed using SPAdes 3.12 [10], and removal of contigs of less than 200 bp was 
carried out with BBMap 38.06 at http://sourceforge.net/projects/bbmap/. To assess the quality of the 
assembled genome, Quality Assessment Tool for Genome Assemblies QUAST 4.1 was utilized along with 
Python 2.7 [11]. 
2.3. Annotation of Genomes 
The assembled genomes were annotated using Prokka 1.13 [12], and the National Center for 
Biotechnology Information (NCBI) Prokaryotic Genome Annotation Pipeline (PGAP) 4.11 
(https://www.ncbi.nlm.nih.gov/genome/annotation_prok/) for each strain [13]. The genomes were 
evaluated for the presence of plasmids using PlasmidFinder 2.0 [14]. The assessment of acquired 
antibiotic resistance genes and virulence factors was performed using ResFinder 3.1 and VirulenceFinder 
2.9 [15], respectively, which were available in the Center for Genomic Epidemiology server at 
http://www.genomicepidemiology.org/. 
2.4. Comparison of Genomic Content 
The CSI Phylogeny software was used to detect, filter, and then generate a SNP pairwise matrix for 
all the nucleotide differences present in the F. tularensis type B genomes. To generate phylogenetic trees, 
the files were converted to a Newick format, and rooted trees were created using the CSI Phylogeny tool. 
To visualize and annotate the dendrograms, the Interactive Tree of Life (iTOL) online tool at 
https://itol.embl.de/upload.cgi was utilized. Roary 3.12.0 was utilized to assess the pan-genome for the 
detection of the presence and absence of genes in the six sequenced wild-type isolates relative to the 
reference F. tularensis type B strain FSC200 (NCBI Reference Sequence NC_019551.1, GenBank accession 
number CP003862) [16]. Genome alignments were performed using the progressiveMauve software tool 
[17]. Default parameters were used for all software unless otherwise specified, and bioinformatic tools 
were utilized on the GitHub platform https://github.com/. 
2.5. Data Availability 
The whole genome sequences for the F. tularensis type B strains NE-RWMC-071715A, NE-RWMC-
071715B, NE-RWMC-082115, NE-RWMC-083115, NE-RWMC-101314, and NE-RWMC-101714 were 
deposited in NCBI BioProject number PRJNA663584 and are associated with BioSample numbers 
SAMN16136936, SAMN16136935, SAMN16136934, SAMN16136933, SAMN16136932, and 
SAMN16136931; Sequence Read Archive (SRA) numbers SRR12644162, SRR12644163, SRR12644164, 
SRR12644165, SRR12644166, and SRR12644167; and GenBank accession numbers JACWLF000000000, 
JACWLG000000000, JACWLH000000000, JACWLI000000000, JACWLJ000000000, and 
JACWLK000000000, respectively. The strain designations for these six wild-type F. tularensis isolates 
denote the abbreviation for the associated state (i.e., Nebraska) and hospital (i.e., Regional Western 
Medical Center), and the six digit numbers (i.e., mmddyy) denote the month, day, and year that the wild-
type strain was archived into the UNMC/NPHL database and stock collection, which was around three 
days after the initial isolation of the associated pathogen. 
3. Results 
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Six patients admitted to the same hospital in western Nebraska (longitude W-103.662024, latitude N 
41.867089) between October 2014 and August 2015 had symptoms of an infection, which included fever, 
chills, nausea, headache, hypotension, and an elevated white blood cell count. These individuals were 
given antibiotics to prevent further complications, based on their clinical presentation. Blood drawn from 
these patients prior to antibiotic treatment was cultured on various media, using different growth 
conditions and incubation lengths (1-3 days). Next, the criteria established by the CDC national 
Laboratory Response Network for the initial identification of a potential F. tularensis isolate were 
implemented. This process involves a rule-in/rule-out process that includes the visualization of colony 
morphology, Gram staining, and biochemical testing. All six wild-type isolates required a minimum of 2 
days for visible growth on medium that contained a sulfhydryl source (i.e., cysteine or cystine). 
Morphological examinations of these microbes revealed a nonmotile, nonsporulating, Gram-negative 
coccobacillus, and biochemical testing showed that all six of these isolates were oxidase negative. 
To confirm the identification of the infectious blood-derived pathogens as F. tularensis, the cultures 
were transported to NPHL. Real-time PCR assays recommended by the CDC were performed and all 
three F. tularensis gene targets (FT1, FT2, and FT3) were detected and amplified in each of the six wild-
type isolates. These assays provided qualitative detection of F. tularensis genomic DNA, but only 
presumptive identification. To confirm the identification of these isolates, direct fluorescence antibody 
(DFA) analyses from culture were performed using a rabbit polyclonal antibody that detects an F. 
tularensis-specific antigen. All six wild-type isolates were positive in the DFA test. Additional PCR-based 
assays were then performed for typing of the F. tularensis isolates, as previously described [18,19]. These 
analyses determined that all six of these blood-derived pathogens were F. tularensis subspecies holarctica 
(type B) in these clinical cases. A stock culture of these six select agent strains was then made by 
authorized individuals for long-term storage in the Select Agent-registered UNMC/NPHL high-
containment BSL-3 facility. 
To further evaluate these six wild-type F. tularensis isolates, the genomic DNA from these pathogens 
was extracted and sequenced. The assembly of the six F. tularensis genomes resulted in 98 to 101 
contiguous sequences or contigs, with the longest fragment containing 88,291 bp. The total length 
obtained for the six bacterial chromosomes ranged from 1,787,790 to 1,790,384 bp, which translates to an 
estimated coverage of 94.5%. N50 lengths are often used as a measure of assembly quality, capturing how 
much of the genome is covered by relatively large contigs [20]. The N50 (bp) acquired for the contigs 
associated with the six F. tularensis genomes was between 27001–25313, which statistically conveys high 
assembly quality in terms of contiguity. The average G+C content for these six genomes was determined 
to be 32.16–32.18%, which is similar to the majority of other select agent strains in this species [21,22]. 
Next, the genomic content for these six F. tularensis type B isolates was compared to each other and 
to the reference type B strain FSC200. F. tularensis FSC200 was isolated from a child in 1998 that lived in 
an area in Sweden where tularemia is endemic due to infections by this subspecies and is the most studied 
type B select agent strain [4,23]. Sequence comparison of the six F. tularensis type B strains to FSC200 
indicated that no additional plasmids, antibiotic resistance genes, or virulence factors were acquired. The 
chromosomal alignments shown in Figure 1 compare the local collinear blocks (LCBs) that were obtained 
from the WGS of the six type B strains relative to each other and to FSC200. These results showed that 
the six F. tularensis type B strains shared similar nucleotide content to each other (Figure 1A), as well as 
to FSC200 (Figure 1B and 1C). However, in order to compare overall genomic content and organization, 
complete chromosomal assembly is required, but the numerous insertion sequence elements and 
repeated sequences within the F. tularensis select agent strains make this an arduous and time-consuming 
task. 





Figure 1. Diagram depicting local collinear blocks (LCBs) within the genomes of the six wild-type F. 
tularensis type B isolates compared to the reference type B strain FSC200. (A) Comparison of the LCBs 
obtained for F. tularensis strains RWMC-071715A, RWMC-071715B, RWMC-082115, RWMC-083115, 
RWMC-101314, and RWMC-101714. (B), (C) Comparison of the LCBs for a representative F. tularensis type 
B strain (RWMC-071715A) with the reference type B strain FSC200 (NCBI reference sequence 
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NC_019551.1, GenBank accession number CP003862), before and after contig correlation to FSC200, 
respectively. The large white LCBs in FSC200 denote missing WGS data in RWMC-071715A in Figure 1C. 
These regions at nucleotide positions 100,370–129,503 and 1,096,979-1,126,076 in FSC200 contained two 
additional copies of the genes encoding 16S ribosomal RNA (rRNA), 23S rRNA, 5S rRNA, and transfer 
RNA, as well as insertion sequence elements and hypothetical genes. Contigs less than 128 bp were not 
included in the comparison to FSC200 in Figure 1B and C. Each LCB is represented with a different pattern 
and/or shading. An LCB depicted below the center line indicates that the sequence is reverse/complement, 
and the relative nucleotide lengths are denoted in base pairs above the corresponding genome. The 
progressiveMauve software tool was used to align the genomes [17]. 
Table 1 compares the SNP content in the WGS obtained for the six F. tularensis type B strains that 
were isolated from the blood of patients in the United States during a one-year period to each other and 
to the prototype strain FSC200. The six United States strains showed substantially higher homology to 
each other than to the type B reference FSC200, with more than 519 SNP differences identified between 
these geographically separated isolates. Five of the six F. tularensis United States type B isolates had fewer 
than 23 SNPs, indicating that these strains were closely related to each other. In contrast, RWMC-082115 
had more than 46 SNPs compared to the other five United States isolates (Table 1). RWMC-101314 and 
RWMC-071715A shared the highest WGS identity with only four SNPs, even though these pathogens 
were isolated from the blood of distinct patients in two different years. However, these four SNPs were 
located at different regions within the chromosome of these two strains, and only RWMC-071715A 
shared these polymorphisms with FSC200. Although RWMC-071715A and RWMC-071715B were 
isolated on the same day from two separate individuals at the same hospital, WGS results showed a 
difference of 22 nucleotides between these two strains (Table 1). Together, these results indicated that 
despite these nucleotide differences, these six F. tularensis type B strains maintained the ability to cause 
the highly infectious disease tularemia. 
Table 1. Whole genome sequencing (WGS) single nucleotide polymorphism (SNP) pairwise matrix for 
the six F. tularensis type B strains isolated from the same region in the United States within a one-year 
period relative to each other and to the prototype type B strain FSC200 1,2. 
 FSC200 071715A 071715B 082115 083115 101314 101714 
FSC200 0 528 525 524 526 526 520 
071715A 528 0 22 49 17 4 12 
071715B 525 22 0 53 21 20 22 
082115 524 49 53 0 48 47 49 
083115 526 17 21 48 0 15 17 
101314 526 4 20 47 15 0 10 
101714 520 12 22 49 17 10 0 
1 The six F. tularensis type B strains from the United States are denoted without the prefix RWMC. 2 The 
SNP pairwise matrix was generated using the CSI Phylogeny tool. 
In order to compare the genomic content of genes shared between the six F. tularensis type B strains 
isolated from the same region in the United States and reference strain FSC200, pairwise matrix SNP 
content in the core genome was obtained and evaluated (Table 2). These data showed similar results to 
what was obtained for the WGS pairwise matrix SNP comparisons, which is shown in Table 1. However, 
there were slightly fewer SNP differences in shared genes in the six United States type B and FSC200 
genomes, compared to the SNP content obtained for the WGS comparisons. These results suggested that 
these nucleotide differences are within coding regions, which could possibly alter the function of the 
gene products if these mutations are nonsynonymous. Furthermore, there was again a considerably 
higher number of core genome SNPs (> 518) in the six United States type B strains relative to FSC200 
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(Table 2), which was similar to the 519 SNPs obtained for the WGS comparisons (Table 1). RWMC-101314 
and RWMC-071715A, which shared the highest WGS identity with only four SNPs, again only had four 
SNPs when comparing the core genome for these two strains, further indicating clonal relatedness 
between these 2014 and 2015 isolates, respectively. 
Table 2. Single nucleotide polymorphism (SNP) pairwise matrix for the core genome from the six F. 
tularensis type B strains isolated from the same region in the United States within a one-year period 
relative to each other and to the prototype type B strain FSC200 1,2. 
 FSC200 071715A 071715B 082115 083115 101314 101714 
FSC200 0 523 524 520 522 521 519 
071715A 523 0 17 47 15 4 4 
071715B 524 17 0 48 16 15 13 
082115 520 47 48 0 46 45 43 
083115 522 15 16 46 0 13 11 
101314 521 4 15 45 13 0 2 
101714 519 4 13 43 11 2 0 
1 The six F. tularensis type B strains from the United States are denoted without the prefix RWMC. 2 The 
SNP pairwise matrix was generated using the CSI Phylogeny tool. 
The clustering patterns shown in Figure 2 for the rooted tree were obtained for both the WGS and 
core genome SNP comparison, and further depict the close relatedness of the six United States type B 
isolates, and the considerable divergence of these strains from F. tularensis FSC200. Although these six 
United States strains shared considerable genomic content to each other, the higher number of SNPs in 
RWMC-082115 compared to the five other strains from this region resulted in a separate branch in the 
phylogenetic tree (Figure 2). However, no obvious differences were observed in the clinical presentation 
caused by RWMC-082115 compared to these other United States type B strains. Nucleotide composition 
comparisons of the SNPs in the aforementioned F. tularensis strains revealed that FSC200 had a slightly 
higher A+T content (3%) compared to the six United States type B strains. 
 
Figure 2. Phylogenetic analysis of the WGS and core genome SNPs obtained for the six wild-type F. 
tularensis type B strains isolated from the blood of infected individuals from the same region in the United 
States with tularemia, along with prototype strain FSC200 for comparison. The rooted dendrogram was 
generated with the CSI Phylogeny tool and the resulting SNP-based tree was obtained for both analyses. 
A correlation coefficient of 0.99 was obtained for this analysis. 
4. Discussion 
The positive identification of F. tularensis type B in peripheral blood obtained from patients with 
symptoms of an infection (i.e., fever, chills, and nausea) was confirmed in six different clinical cases from 
the same region within a one-year period. These bloodstream infections could have led to septic shock, 
organ failure, and then ultimately death had immediate antibiotic treatment not been given to these 
patients. Although the majority of tularemia cases in the United States are due to the hypervirulent 
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subtype A.I clade and not type B strains [6], the current report emphasizes that all select agent strains 
from this species are capable of causing bacteremia and potentially mortality. Furthermore, the 
comparison of these isolates with the prototype F. tularensis FSC200 strain from Europe revealed a 
substantial number of SNPs. These findings suggest that although the type B clade is considered more 
clonal than the A.I and A.II strains [18,24], this subpopulation is still highly pathogenic despite the 
apparent accumulation of SNPs. 
In 2015, the CDC reported on a substantial increase in the human cases of tularemia in Nebraska, 
Colorado, Wyoming, and South Dakota [25]. These clinical cases included the four type B strains 
described in this communication, specifically RWMC-071715A, RWMC-071715B, RWMC-082115, and 
RWMC-083115. In this tularemia outbreak, some of the infected individuals suggested two or more 
possible causes; however, the source of F. tularensis was never verified. Although the source of F. 
tularensis in clinical cases is often unknown, hard ticks are generally considered the main biological vector 
of tularemia in North America [26,27]. However, other infected organisms, especially predatory animals 
[5], along with contaminated air, food, and water, can also be responsible for transmitting this pathogen 
to another vector or host [3]. Therefore, the multidirectional nature of zoonosis and the broad host range 
of F. tularensis have complicated epidemiological investigations for the identification of tularemia foci in 
the environment. 
Although the F. tularensis subspecies holarctica (type B) strains have fewer genomic rearrangements 
than the other clinically relevant subspecies of tularensis [18,24], erythromycin sensitivity versus 
resistance biovars, canonical SNP (canSNP) analyses, and chromosomal content have been used to 
identify and classify type B strains into various subgroups [18,19,28,29]. Karlsson and associates 
determined that the A2059C SNP in the 23S ribosomal RNA gene was conserved in biovar II strains and 
conferred the associated resistance to erythromycin [28]. Since this SNP is also found in the most 
abundant subgroup B.12 in Eurasia that includes FSC200, the authors suggested that this clonal 
inheritance may have contributed to the success of this phylogenetic group. The six type B strains 
analyzed in this report did not have the A2059C SNP in the 23S ribosomal RNA gene, but rather had two 
other mutations (G449A and C2052A) compared to FSC200, suggesting that other factors have influenced 
the prevalence of these pathogenic isolates. 
Many bacteria subjected to relaxed selection are often intracellular and, in general, reside or replicate 
within the infected host cell with a limited chance of recombining or exchanging DNA with other bacteria 
[30–32]. Moreover, GC to AT mutations have been shown to occur approximately twice as often as AT to 
GC mutations and seem to be more readily fixed within the genome [33,34]. The slightly higher A+T 
content in F. tularensis FSC200 compared to the six United States type B strains described in this report 
suggests that this European isolate was subjected to more conditions that provided relaxed purification, 
which led to the accumulation of these AT mutations. Conversely, one cannot rule out the possibility that 
the United States type B strains may have encountered stringent selection, which prevented or reduced 
G/C to A/T allelic modifications. 
The analysis of canSNPs and canonical insertions/deletions (canINDELs) in F. tularensis genomes 
has certainly improved the ability to correlate lineages and geographical associations [35–38]. However, 
Johannsson and associates determined that a tularemia outbreak in Europe was caused by diverse type 
B strains with no significant correlation between genetic, spatial, or temporal distances [39]. Therefore, 
additional study is needed to provide a better understanding of the mechanisms that allow F. tularensis 
to persist in nature and evade immune surveillance during an infection. 
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